gip/glp-1 agonists GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models — Hayes Lab GI Adverse Effects of Glucagon-Like

In the Golgi apparatus, TMEM165 (Potelle et al., 2016) and SPCA1 (Leitch et al., 2011

These unique structural features, particularly the way it engages with the receptors, are proposed to contribute to its potent and long-acting clinical efficacy as a dual agonist for weight management

While there is no concrete clinical proof that spirulina can directly decrease the desire for alcohol, there is a potential indirect method that deserves attention

This approach of senescent T-cells elimination has a great potential to restore immune system function and therefore, to protect the aged animal against numerous aging-associated disorders 70